Hughes Hubbard & Reed represented DASI, LLC in the transaction. Leading global aircraft inventory solutions provider DASI announced the sale of 50% of the outstanding ownership of...
Marubeni Corporation’s Acquisition of 50% of DASI
Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy
Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal. Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used...